See, § F.2.  A trial lasts 30 to 60 days, at which time there is to be demonstrated sustained improvement in function and pain with the patient monitored weekly.  The goal is a 30% reduction in pain, return to work, an increase in activities of daily living, no significant adverse side effects, and no aberrant drug-related behaviors.  